This week, Shawn Wilkie and Dr. Ivan Zak welcome Alex Voda from The Cat Health Company to discuss how the startup became the first clinical-stage company focused on feline longevity. Alex explains why cats are better models than other species for pharmaceutical R&D and how repurposing existing drugs could accelerate new treatments.  He shares insights into why longevity companies still move slowly, highlights common and unique feline aging mechanisms, and reflects on what these innovations could mean for veterinarians, pet owners, and the broader future of veterinary practice. Learn more about The Cat Health Company. Alex recommends Youtube - Alex Zhavoronkov at ARDD2024: Methylation Clocks and AI Life Models as Sources of Therapeutic Target.

Ver todos los episodios